95 related articles for article (PubMed ID: 8215486)
21. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
22. Plasma pepsinogen in health and gastroduodenal disorders.
Naganna B; Balasundaram D; Venkaiah KR
J Indian Med Assoc; 1972 Jan; 58(1):6-9. PubMed ID: 5021272
[No Abstract] [Full Text] [Related]
23. [Diagnostic and therapeutic strategies in local recurrence of stomach carcinoma].
Schumacher IK; Bernhardt J; Petermann J; Lorenz D
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1373-6. PubMed ID: 9931886
[TBL] [Abstract][Full Text] [Related]
24. [Significance of surgical treatment for recurrent gastric cancer].
Kikuchi K; Natsume R; Kunii Y
Iryo; 1967 Jan; 21(1):86-92. PubMed ID: 6037011
[No Abstract] [Full Text] [Related]
25. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
[TBL] [Abstract][Full Text] [Related]
26. A novel tree-structured analysis for non-invasive diagnosis of gastric adenocarcinoma.
Wu MS; Lee WC; Lin JT; Wang HP; Wang TH; Chen CJ
Anticancer Res; 1995; 15(6B):2739-43. PubMed ID: 8669856
[TBL] [Abstract][Full Text] [Related]
27. Lansoprazole elevates the ratio of serum pepsinogen I v.s. pepsinogen II.
Matsukawa Y; Nishinarita S; Kaneko M; Takei M; Murakami M; Horie T; Kawamura F; Arakawa Y; Kuwayama H; Kurosaka H
Int J Clin Pharmacol Res; 1997; 17(4):127-32. PubMed ID: 9526173
[TBL] [Abstract][Full Text] [Related]
28. Tumor recurrence and its timing following curative resection of early gastric carcinoma.
Otsuji E; Kuriu Y; Ichikawa D; Okamoto K; Hagiwara A; Yamagishi H
Anticancer Res; 2003; 23(4):3499-503. PubMed ID: 12926097
[TBL] [Abstract][Full Text] [Related]
29. [Clinical significance of serum group I pepsinogen level in gastric duodenal diseases].
Noguchi M; Nakajima K; Yoshii M; Kono S; Aoki E; Tanaka K; Adachi H; Torizuka K
Nihon Shokakibyo Gakkai Zasshi; 1983 Feb; 80(2):131-9. PubMed ID: 6865060
[No Abstract] [Full Text] [Related]
30. A minute gastric cancer detected by a new screening method using serum pepsinogen I and II.
Yahagi N; Miki K; Ichinose M; Kakei N; Matsushima M; Kido M; Shimizu Y; Ishihama S; Tsukada S; Kurokawa K
Adv Exp Med Biol; 1995; 362():145-8. PubMed ID: 8540313
[No Abstract] [Full Text] [Related]
31. Serum pepsinogen I as a predictor of stomach cancer.
Nomura AM; Stemmermann GN; Samloff IM
Ann Intern Med; 1980 Oct; 93(4):537-40. PubMed ID: 7436185
[TBL] [Abstract][Full Text] [Related]
32. Pepsinogen A (I) isozymogens in normal gastric mucosa and in malignant tissue from patients with gastric cancer.
Pals G; Westerveld BD; Pronk JC; Bosma A; Eriksson AW; Meuwissen SG
Neth J Med; 1985; 28(10):463-9. PubMed ID: 4080047
[No Abstract] [Full Text] [Related]
33. Clinical significance of gastric outlet obstruction on the oncologic and surgical outcomes of radical surgery for carcinoma of the distal stomach.
Park SH; Mok YJ; Kim JH; Park SS; Kim SJ; Kim CS
J Surg Oncol; 2009 Sep; 100(3):215-21. PubMed ID: 19235783
[TBL] [Abstract][Full Text] [Related]
34. [Postoperative recurrence of T2 stage gastric cancer].
Yuan X; Shao Y; Cui X; Zheng C
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):499-501. PubMed ID: 11832091
[TBL] [Abstract][Full Text] [Related]
35. Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients.
Choi JH; Oh JY; Ryu SK; Kim SJ; Lee NY; Kim YS; Yi SY; Shim KS; Han WS
Cancer; 1997 May; 79(10):1879-83. PubMed ID: 9149012
[TBL] [Abstract][Full Text] [Related]
36. [Myoid tumours of the stomach (apropos of 3 cases)].
Leger L; Hamel D; Lemaigre G; Delaitre B
J Chir (Paris); 1972 Mar; 103(3):205-20. PubMed ID: 5056645
[No Abstract] [Full Text] [Related]
37. Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach.
Parthasarathy G; Maroju NK; Kate V; Ananthakrishnan N; Sridhar MG
Trop Gastroenterol; 2007; 28(4):166-70. PubMed ID: 18416347
[TBL] [Abstract][Full Text] [Related]
38. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
[TBL] [Abstract][Full Text] [Related]
39. [Clinical and prognostic significance of protein and gene expression of orotate phosphoribosyltransferase in gastric carcinoma].
Sakurai Y; Yoshida I; Tonomura S; Inaba K; Shoji M; Nakamura Y; Uyama I; Komori Y; Ochiai M; Kamoshida S; Tsutsumi Y
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1111-8. PubMed ID: 16912530
[TBL] [Abstract][Full Text] [Related]
40. [Influence of histologic type on prognosis of patients undergoing curative intervention for gastric adenocarcinoma. Italian multicenter study].
de Manzoni G; Roviello F; Marrelli D; Morgagni P; Di Leo A; Saragoni L; De Stefano A; Bazzocchi F; Pinto E
Ann Ital Chir; 2001; 72(1):13-8. PubMed ID: 11464489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
